0001615219-20-000025.txt : 20200325
0001615219-20-000025.hdr.sgml : 20200325
20200325180221
ACCESSION NUMBER: 0001615219-20-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200323
FILED AS OF DATE: 20200325
DATE AS OF CHANGE: 20200325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arthur David J.
CENTRAL INDEX KEY: 0001769331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 20743408
MAIL ADDRESS:
STREET 1: 2450 HOLCOME BLVD.
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_158517372311926.xml
FORM 4
X0306
4
2020-03-23
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001769331
Arthur David J.
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOME BLVD., SUITE J-608
HOUSTON
TX
77021
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
0.61
2020-03-23
4
A
0
60000
0
A
2030-03-22
Common Stock
60000.0
60000
D
25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years.
/s/ David J. Arthur
2020-03-25